Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line and Ready-to-Use, High-Quality Neural Progenitor Cells for Downstream Differentiation Applications

On June 29, 2023, STEMCELL Technologies' Dr. Andrew Gaffney and Dr. Erin Knock presented on how to streamline PSC-related workflows using highly characterized induced pluripotent stem cells (iPSCs) and neural progenitor cells (NPCs), and how to differentiate these cells into a variety of cell types downstream. In this Q&A report, you can read their answers to questions asked by the audience. Answers have been edited for length and/or clarity.

  • Cellular Brain Repair for Parkinson's Disease

Cellular Brain Repair for Parkinson’s Disease: Is the Answer in the (Biomaterial) Matrix?

, , |

Join Eilís Dowd, PhD who will highlight her lab's recent data demonstrating that dopaminergic cell replacement in the Parkinsonian rodent brain, using both fetal and induced stem cell-derived cells, is enhanced when the cells are transplanted in a neurotrophin-enriched collagen hydrogel.

  • Talking Real Science with Oliver Wearing

Talking Real Science with Oliver Wearing

Oliver Wearing shares what led him to study the relationship between cardiovascular physiology and the autonomic nervous system, how achieving his various positions and awards have allowed him to pursue his research goals, and where he hopes to take his work next.

Go to Top